Since he founded the Carlsbad (Calif.) biotech company Invitrogen Corp. in 1988, Chief Executive Lyle C. Turner has given his business spiel at dozens of investor meetings. "Usually, about seven people would show up," he says. Not anymore. When Turner spoke at a health-care conference in San Francisco in January, it was standing-room only, "with at least 300 people in the room," he says. To Turner, that's proof that a new generation of investors is discovering biotechnology. And for many, it's love at first sight.
展开▼
机译：自1988年创立卡尔斯巴德（加利福尼亚州）生物技术公司Invitrogen Corp.以来，首席执行官Lyle C. Turner在数十次投资者会议上发表了自己的商业见解。他说：“通常，大约会有七个人出现。”不再。他说，当特纳在一月份在旧金山举行的一次卫生保健会议上发表讲话时，它只是站在房间里，“房间里至少有300人。”对于特纳，这证明了新一代投资者正在发现生物技术。对于许多人来说，这是一见钟情。
展开▼
